Nuvectra Corp Company Profile (NASDAQ:NVTR)

About Nuvectra Corp (NVTR)

Nuvectra Corp logoNuvectra Corporation is a neurostimulation company that focuses on helping physicians to improve the lives of people with chronic neurological conditions. The Company's Algovita Spinal Cord Stimulation (SCS) System (Algovita) is the Company's commercial offering and is Conformite Europeene (CE) marked and the United States Food and Drug Administration (FDA) approved for the treatment of chronic pain of the trunk and/or limbs. Its technology platform also has capabilities under development to support other neurological indications, such as sacral nerve stimulation (SNS) and deep brain stimulation (DBS). In addition, its NeuroNexus Technologies, Inc. (NeuroNexus) subsidiary designs, manufactures and markets neural-interface technologies for the neuroscience clinical research market. Its Virtis is an application of the Company's neurostimulation technology platform and its first product for the SNS market. Its subsidiaries include Algostim, LLC (Algostim) and PelviStim LLC (PelviStim).

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: NVTR
  • CUSIP: N/A
Key Metrics:
  • Previous Close: $6.15
  • 50 Day Moving Average: $7.10
  • 200 Day Moving Average: $6.28
  • 52-Week Range: $10,337,000.00 - $4.17
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -2.16
  • P/E Growth: 0.00
  • Market Cap: $66.47M
  • Outstanding Shares: 10,337,000
Profitability:
  • Net Margins: -320.73%
  • Return on Equity: -33.89%
  • Return on Assets: -28.02%
Debt:
  • Debt-to-Equity Ratio: 0.13%
  • Current Ratio: 7.33%
  • Quick Ratio: 7.33%

Analyst Ratings

Consensus Ratings for Nuvectra Corp (NASDAQ:NVTR) (?)
Ratings Breakdown: 1 Hold Rating, 2 Buy Ratings
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $12.00 (86.63% upside)

Analysts' Ratings History for Nuvectra Corp (NASDAQ:NVTR)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
3/13/2017B. RileyReiterated RatingBuy$12.00LowView Rating Details
8/13/2016Piper Jaffray CompaniesReiterated RatingNeutral$12.00 -> $10.00N/AView Rating Details
6/3/2016Sterne Agee CRTInitiated CoverageBuy$14.00N/AView Rating Details
(Data available from 3/26/2015 forward)

Earnings

Earnings History for Nuvectra Corp (NASDAQ:NVTR)
Earnings by Quarter for Nuvectra Corp (NASDAQ:NVTR)
Earnings History by Quarter for Nuvectra Corp (NASDAQ:NVTR)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/9/2017        
3/7/2017Q4 2016($0.89)($1.27)$3.97 million$4.20 millionViewListenView Earnings Details
11/9/2016Q3 2016($0.88)($0.92)$2.81 million$3.80 millionViewListenView Earnings Details
8/10/2016Q216($1.13)($0.85)$2.40 million$2.50 millionViewListenView Earnings Details
5/11/2016Q1($0.51)($0.70)ViewListenView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Nuvectra Corp (NASDAQ:NVTR)
Current Year EPS Consensus Estimate: $-4.36 EPS
Next Year EPS Consensus Estimate: $-2.97 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q4 20161($0.97)($0.97)($0.97)
Q1 20171($1.25)($1.25)($1.25)
Q2 20171($1.16)($1.16)($1.16)
Q3 20171($1.15)($1.15)($1.15)
Q4 20171($0.80)($0.80)($0.80)
Q1 20181($0.77)($0.77)($0.77)
Q2 20181($0.83)($0.83)($0.83)
Q3 20181($0.72)($0.72)($0.72)
Q4 20181($0.64)($0.64)($0.64)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Nuvectra Corp (NASDAQ:NVTR)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Nuvectra Corp (NASDAQ:NVTR)
Institutional Ownership Percentage: 61.35%
Insider Trades by Quarter for Nuvectra Corp (NASDAQ:NVTR)
Institutional Ownership by Quarter for Nuvectra Corp (NASDAQ:NVTR)
Insider Trades by Quarter for Nuvectra Corp (NASDAQ:NVTR)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/16/2017Joseph A MillerDirectorBuy25,000$6.11$152,750.00View SEC Filing  
3/14/2017Scott F DreesCEOBuy25,000$6.21$155,250.00View SEC Filing  
1/4/2017Thomas Kelley HickmanEVPSell133$5.36$712.88View SEC Filing  
5/19/2016David D JohnsonDirectorBuy30,000$14.02$420,600.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Nuvectra Corp (NASDAQ:NVTR)
Latest Headlines for Nuvectra Corp (NASDAQ:NVTR)
Source:
DateHeadline
americanbankingnews.com logoZacks: Analysts Set $12.00 Price Target for Nuvectra Corp (NVTR)
www.americanbankingnews.com - March 22 at 10:31 AM
americanbankingnews.com logoNuvectra Corp (NVTR) Director Acquires $152,750.00 in Stock
www.americanbankingnews.com - March 20 at 7:55 PM
finance.yahoo.com logoNUVECTRA CORP Financials
finance.yahoo.com - March 15 at 7:07 PM
biz.yahoo.com logoNUVECTRA CORP Files SEC form 10-K, Annual Report
biz.yahoo.com - March 9 at 6:46 PM
seekingalpha.com logoNuvectra Corporation (NVTR) Presents At Cowen and Company 37th Annual Health Care Conference
seekingalpha.com - March 8 at 7:42 PM
biz.yahoo.com logoQ4 2016 Nuvectra Corp Earnings Release - Before Market Open
us.rd.yahoo.com - March 7 at 11:47 PM
nasdaq.com logoNuvectra™ Reports Fourth Quarter and Full Year 2016 Financial Results
www.nasdaq.com - March 7 at 10:02 AM
seekingalpha.com logoNuvectra Corporation misses by $0.38, beats on revenue
seekingalpha.com - March 7 at 10:02 AM
biz.yahoo.com logoNUVECTRA CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
biz.yahoo.com - March 7 at 10:02 AM
finance.yahoo.com logoNuvectra to Present at the 29th Annual ROTH Conference
finance.yahoo.com - March 6 at 8:04 AM
finance.yahoo.com logoNuvectra to Present at the Cowen and Company 37th Annual Health Care Conference
finance.yahoo.com - March 1 at 10:30 AM
finance.yahoo.com logoNuvectra to Report Fourth Quarter 2016 Financial Results on March 7, 2017
finance.yahoo.com - February 21 at 5:56 PM
us.rd.yahoo.com logoNuvectra Extends Timeline of Existing Credit Facility
us.rd.yahoo.com - February 14 at 10:12 PM
finance.yahoo.com logoNuvectra to Present at the Leerink Partners 6th Annual Global Healthcare Conference
finance.yahoo.com - February 6 at 9:26 AM
us.rd.yahoo.com logoNuvectra Files Regulatory Submissions for FDA and CE Mark Approvals of the Virtis™ Sacral Nerve Stimulation (SNS) System
us.rd.yahoo.com - February 1 at 8:04 PM
us.rd.yahoo.com logo10:01 am Nuvectra files regulatory submissions with the FDA and CE Mark authorities for Virtis
us.rd.yahoo.com - February 1 at 8:04 PM
biz.yahoo.com logoNUVECTRA CORP Files SEC form 8-K, Change in Directors or Principal Officers
biz.yahoo.com - January 17 at 7:18 PM
finance.yahoo.com logoNuvectra Receives Frost & Sullivan’s New Product Innovation Award for Its Algovita® SCS System
finance.yahoo.com - January 17 at 11:25 AM
finance.yahoo.com logoNuvectra Corporation Signs Direct Supply Agreement
finance.yahoo.com - December 12 at 9:57 AM
finance.yahoo.com logo8:01 am Nuvectra completes a direct supply agreement with Minnetronix; will begin purchasing the external peripheral devices for its Algovita spinal cord stimulation system directly from Minnetronix in the first half of 2017 as it transitio
finance.yahoo.com - December 12 at 9:57 AM
finance.yahoo.com logoNuvectra to Present at the 28th Annual Piper Jaffray Healthcare Conference
finance.yahoo.com - November 21 at 11:52 AM
seekingalpha.com logoNuvectra Corporation misses by $0.04, beats on revenue
seekingalpha.com - November 10 at 9:37 AM
biz.yahoo.com logoQ3 2016 Nuvectra Corp Earnings Release - After Market Close
biz.yahoo.com - November 9 at 9:03 AM
finance.yahoo.com logoNuvectra to Report Third Quarter 2016 Financial Results on November 9, 2016
finance.yahoo.com - November 2 at 6:50 PM
seekingalpha.com logoNuvectra: Post Spin-Off
seekingalpha.com - October 5 at 11:45 AM
seekingalpha.com logoAptevo Therapeutics: A Biotech Spinoff With Potential
seekingalpha.com - September 22 at 11:19 AM
finance.yahoo.com logoEdited Transcript of NVTR earnings conference call or presentation 10-Aug-16 8:30pm GMT
finance.yahoo.com - August 18 at 6:43 PM
streetinsider.com logoPiper Jaffray Cuts Price Target on Nuvectra Corporation (NVTR) Following 2Q Revenue Beat
www.streetinsider.com - August 12 at 9:45 AM
biz.yahoo.com logoQ2 2016 Nuvectra Corp Earnings Release - After Market Close
biz.yahoo.com - August 10 at 9:40 AM
finance.yahoo.com logoMedical Products' Earnings on Aug 10: PRGO, NVTR & BSGM
finance.yahoo.com - August 9 at 9:45 AM
finance.yahoo.com logoNuvectra Announces Formation of Medical Advisory Board
finance.yahoo.com - August 8 at 11:15 AM
biz.yahoo.com logoNUVECTRA CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits
biz.yahoo.com - August 1 at 6:19 PM
finance.yahoo.com logoNuvectra to Report Second Quarter 2016 Financial Results on August 10, 2016
finance.yahoo.com - July 27 at 4:01 PM
finance.yahoo.com logoNuvectra Added to the Russell Microcap® Index
finance.yahoo.com - June 28 at 9:00 AM
biz.yahoo.com logoNUVECTRA CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
biz.yahoo.com - June 17 at 4:32 PM
finance.yahoo.com logoCoverage initiated on Nuvectra by Sterne Agee CRT
finance.yahoo.com - June 3 at 7:12 AM
biz.yahoo.com logoNuvectra Corp Earnings Call scheduled for 4:30 pm ET today
biz.yahoo.com - May 11 at 4:30 PM

Social

Frequently Asked Questions for Nuvectra Corp (NASDAQ:NVTR)

What is Nuvectra Corp's stock symbol?

Nuvectra Corp trades on the NASDAQ under the ticker symbol "NVTR."

How were Nuvectra Corp's earnings last quarter?

Nuvectra Corp (NASDAQ:NVTR) posted its quarterly earnings data on Tuesday, March, 7th. The company reported ($1.27) earnings per share for the quarter, missing the consensus estimate of ($0.89) by $0.38. The company earned $4.20 million during the quarter, compared to analyst estimates of $3.97 million. Nuvectra Corp had a negative return on equity of 33.89% and a negative net margin of 320.73%. The business's revenue for the quarter was up 223.1% compared to the same quarter last year. During the same period in the previous year, the company earned ($0.55) EPS.

When will Nuvectra Corp make its next earnings announcement?

Nuvectra Corp is scheduled to release their next quarterly earnings announcement on Tuesday, May, 9th 2017.

Where is Nuvectra Corp's stock going? Where will Nuvectra Corp's stock price be in 2017?

3 brokerages have issued 12-month price targets for Nuvectra Corp's shares. Their predictions range from $10.00 to $14.00. On average, they expect Nuvectra Corp's stock price to reach $12.00 in the next twelve months.

Who owns Nuvectra Corp stock?

Nuvectra Corp's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Dimensional Fund Advisors LP (6.81%), Bain Capital Investors LLC (3.18%), Numeric Investors LLC (2.41%), Tudor Investment Corp Et Al (1.94%), Hodges Capital Management Inc. (1.73%) and J. Goldman & Co LP (1.61%). Company insiders that own Nuvectra Corp stock include David D Johnson, Joseph A Miller, Scott F Drees and Thomas Kelley Hickman.

Who sold Nuvectra Corp stock? Who is selling Nuvectra Corp stock?

Nuvectra Corp's stock was sold by a variety of institutional investors in the last quarter, including Oxford Asset Management, Bogle Investment Management L P DE, Tudor Investment Corp Et Al, Dimensional Fund Advisors LP and Gamco Investors INC. ET AL.

Who bought Nuvectra Corp stock? Who is buying Nuvectra Corp stock?

Nuvectra Corp's stock was bought by a variety of institutional investors in the last quarter, including FNY Partners Fund LP, Hodges Capital Management Inc., Renaissance Technologies LLC and Numeric Investors LLC. Company insiders that have bought Nuvectra Corp stock in the last two years include David D Johnson, Joseph A Miller and Scott F Drees.

How do I buy Nuvectra Corp stock?

Shares of Nuvectra Corp can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Nuvectra Corp stock cost?

One share of Nuvectra Corp stock can currently be purchased for approximately $6.43.

Nuvectra Corp (NVTR) Chart for Sunday, March, 26, 2017

This page was last updated on 3/26/2017 by MarketBeat.com Staff